Industry News
Breath test could possibly diagnose colorectal cancer
A new study published in the British Journal of Surgery (BJS) has demonstrated for the first time that a simple breath analysis could be used for colorectal cancer screening. [ + ]
Sirtex to investigate nanoparticle anti-cancer technology
Sirtex Medical (ASX:SRX) has entered a research collaboration with Singapore's SingHealth to explore the applications of Carbon Gage Nanoparticles in combating difficult-to-treat cancers. [ + ]
CSL rebrands Australian businesses
Iconic Australian biotech, CSL, is rebranding its two core business units covering plasma and pharmaceuticals in line with a company global reorganisation. [ + ]
Renewed agreement opens paths to better science for Australia and India
Scientists in Australia and India can look forward to greater levels of cooperation and collaboration after the Australian Academy of Science and Indian National Academy of Science today renewed their commitment to work more closely together. [ + ]
Curtin investigates new treatments for diabetes
A group of Curtin University researchers has been awarded a Diabetes Australia Research Trust Grant for research to improve diabetes treatment, potentially eliminating the need for insulin injection. [ + ]
Optibrium and Digital Chemistry announce technology collaboration to guide drug discovery
Optibrium and Digital Chemistry, providers of software and database solutions for drug discovery, have announced an agreement to collaborate on the integration of Digital Chemistry’s Bioster database of precedented bioisostere replacements with Optibrium’s StarDrop software suite. [ + ]
Biotech Christmas celebrations continue around the country
While some states have already begun Christmas celebrations, three states are about to host AusBiotech's free Christmas events as their final networking events of 2012. [ + ]
Osprey enrols first patient for diabetic limb recovery trial
Osprey Medical (ASX:OSP) has signed up the first of a planned 25 patients for an Australian trial of its Limb Recovery System in diabetic patients with limb infections. [ + ]
Phosphagenics expanding pain patch program
Phosphagenics (ASX:POH) has resolved crystallisation issues holding up its TPM-Oxycodone pain patch project and expanded the program to include another opioid-based product. [ + ]
Iluvien knocked back again on reimbursement in the UK
The UK’s reimbursement agency has knocked back Illuvien again, saying its benefits do not justify the price. [ + ]
‘Retired’ scientists unmask bush graffiti artist
In a remarkable piece of detective work, a team of ‘retired’ CSIRO scientists have revealed the group of artists responsible for the iconic scribbles found on smooth-barked Eucalyptus trees in south-eastern Australia. [ + ]
Scientists identify depression and anxiety biomarker in youths
Scientists from the University of Cambridge have discovered a cognitive biomarker - a biological indicator of a disease - for young adolescents who are at high risk of developing depression and anxiety. Their findings have been published in the journal PLoS ONE. [ + ]
Starpharma emphasises portfolio after VivaGel trial fail
Following news that a phase III trial of VivaGel failed to reach its primary end point, Starpharma (ASX:SPL) has emphasised the potential of its platform technology across multiple applications. [ + ]
Pairing blood test and gene sequencing to detect cancer
Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery. [ + ]
Big Pharma doing more for access to medicine in developing countries than two years ago
The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in developing countries, finds that the industry is doing more than it was two years ago. [ + ]
